Retatrutide is an investigational weight-loss and diabetes medication that functions as a "triple agonist." By mimicking three natural gut hormones (GLP-1, GIP, and glucagon), it reduces appetite, slows digestion, burns fat, and improves metabolism. In clinical trials, this has led to some of the most significant weight reductions ever recorded in pharmacology.
